Outcome of ECMO and CRRT.

Outcome of ECMO and CRRT, Experience of Hospital University MED VI, Oujda, Morocco.

Background:

Although acute kidney injury (AKI) is a frequent complication in patients receiving extracorporeal membrane oxygenation (ECMO), and the CRRT impact is widely studied. The incidence of simultaneous use of ECMO and CRRT remain unclear.

Objective: The investigatore conducted this retrospective study to define the incidence of concomitant CRRT with ECMO therapy and to determine the overall impact of this strategy on patient outcomes such as mortality and renal recovery.

Methods:

The investigatore retrospectively analyzed data of patients of all ages, genders and ethnicities, admitted in the intensive care unit of Mohammed VI University Hospital, Oujda, Morocco, on a cumulative period of 2 years (January 2019 - December 2020). Were enrolled in the study patients who benefited from ECMO, and presented an acute kidney injury afterwards, using 'Microsoft Excel' as a software to utilize the information collected from the computerized patient database. 30 patients were included in the final study.

Study Overview

• Status: Completed
• Conditions: Mortality; Incidence of CRRT With ECMO Therapy; and Renal Recovery
• Intervention / Treatment: Other: supervision the Kidney fonction on ECMO

• Study Type: Observational
• Enrollment (Actual): 30

Contacts and Locations

Study Locations

• Morocco
  • Berkane, Morocco, 9999
    • younes Oujidi

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: Child; Adult; Older Adult
• Accepts Healthy Volunteers: No
• Genders Eligible for Study: All

• Sampling Method: Non-Probability Sample

Study Population

We retrospectively analyzed data of patients of all ages, genders and ethnicities, admitted in the intensive care unit of Mohammed VI University Hospital, Oujda, Morocco, on a cumulative period of 2 years

Description

Inclusion Criteria:

• benefited from ECMO .
• presented an acute kidney injury afterwards

Exclusion Criteria:

• patients who developed AKI before benefitting from ECMO and/or missing data

Study Plan

How is the study designed?

Design Details

• Observational Models: Cohort
• Time Perspectives: Retrospective

Number of groups / cohorts

1

Cohorts and Interventions

Group / Cohort	Intervention / Treatment
ECMO and AKI	Other: supervision the Kidney fonction on ECMO; patients who benefited from ECMO, and presented an acute kidney injury afterwards

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Ecmo and severe AKI requiring CRRT	2 groups of patient was identified on this study : first ones are how developped aki and needek CRRT , 2nd are those who developped aki without CRRT	through study completion, an average of 24 mounths

Collaborators and Investigators

• Sponsor: Mohammed VI University Hospital

Study record dates

Study Major Dates

• Study Start (Actual): January 1, 2019
• Primary Completion (Actual): December 31, 2020
• Study Completion (Actual): December 31, 2020

Study Registration Dates

• First Submitted: August 24, 2021
• First Submitted That Met QC Criteria: August 30, 2021
• First Posted (Actual): September 2, 2021

Study Record Updates

• Last Update Posted (Actual): September 2, 2021
• Last Update Submitted That Met QC Criteria: August 30, 2021
• Last Verified: August 1, 2021

More Information

Terms related to this study

• Keywords: COVID; AKI; CRRT; Ecmo
• Other Study ID Numbers: Unite care

Plan for Individual participant data (IPD)

• Plan to Share Individual Participant Data (IPD)?: No

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No